Institutional members access full text with Ovid®

Share this article on:

Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report

Leibu, Evan MD*; Garakani, Amir MD*; McGonigle, Daniel P. MD*; Liebman, Lauren S. BA*; Loh, Daniella MD*; Bryson, Ethan O. MD*†; Kellner, Charles H. MD*

doi: 10.1097/YCT.0b013e318290fa36
Online Articles

Abstract: We present the case of a young man with a long-standing history of schizophrenia who presented with severe and life-threatening catatonia in the setting of synthetic cannabis use who was successfully treated with electroconvulsive therapy. To our knowledge, this is the first reported case of severe and persistent catatonia in the setting of synthetic cannabis use and the first documented successful treatment.

From the Departments of *Psychiatry and †Anesthesiology, Mount Sinai School of Medicine, New York, NY.

Received for publication January 23, 2013; accepted March 5, 2013.

Reprints: Charles H. Kellner, MD, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place (Box 1230), New York, NY 10029 (e-mail: charles.kellner@mssm.edu).

The authors have no conflicts of interest or financial disclosures to report.

Dr Kellner is supported by a grant from the NIMH.

© 2013 by Lippincott Williams & Wilkins